Database
User
| Compound | Dose | Time | Species | Model | Method | Action | Result | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|---|
| Perhexiline | 100 μM | 5 minutes preincubation | mouse; Crl/CD-l(1CR)BR Swiss | liver mitochondria | Measurement of oxygen uptake | decrease | Positive | p < 0.01 | 193 |
| Amiodarone | 100 μmol/L | rat; Sprague–Dawley | liver mitochondria | Measurement of oxygen uptake | decrease | Positive | p < 0.01 | 4 | |
| Perhexiline | 200 μM | 5 minutes preincubation | mouse; Crl/CD-l(1CR)BR Swiss | liver mitochondria | Measurement of oxygen uptake | decrease | Positive | p < 0.01 | 193 |
| Perhexiline | 400 μM | 5 minutes preincubation | mouse; Crl/CD-l(1CR)BR Swiss | liver mitochondria | Measurement of oxygen uptake | decrease | Positive | p < 0.01 | 193 |
| Perhexiline | 100 μM | 5 minutes preincubation | mouse; Crl/CD-l(1CR)BR Swiss | liver mitochondria | Measurement of oxygen uptake | decrease | Positive | p < 0.05 | 193 |
| benzarone | 100 μmol/L | rat; Sprague–Dawley | liver mitochondria | Measurement of oxygen uptake | decrease | Positive | p < 0.01 | 4 | |
| benzbromarone | 100 μmol/L | rat; Sprague–Dawley | liver mitochondria | Measurement of oxygen uptake | decrease | Positive | p < 0.01 | 4 | |
| benzarone | 100 μmol/L | rat; Sprague–Dawley | liver mitochondria | Measurement of oxygen uptake | decrease | Positive | p < 0.01 | 4 | |
| Pioglitazone | decrease | Positive | 22 | ||||||
| Gentamicin | 5mM | 10min | rat | isolated rat liver (and kidney) mitochondria | Oroboros O2K Oxygraph, complex II-based state 4 respiration | increase | Positive | 316 | |
| promethazine | increase | Positive | 22 | ||||||
| Gentamicin | 5mM | 10min | rat | isolated rat liver mitochondria | Oroboros O2K Oxygraph, complex I-based state 4 respiration | increase | Positive | 316 | |
| benzbromarone | 100 μmol/L | rat; Sprague–Dawley | liver mitochondria | Measurement of oxygen uptake | decrease | Positive | p < 0.01 | 4 | |
| clomipramine | decrease | Positive | 22 | ||||||
| Chlorpromazine | increase | Positive | 22 | ||||||
| Chlorpromazine | decrease | Positive | 22 | ||||||
| imipramine | increase | Positive | 22 | ||||||
| Flufenamic Acid | 2.9 ± 0.3 | rat | isolated rat liver mitochondria | State 2 respiration ( 96-well plate format using a phosphorescent oxygen-sensitive probe MitoXpress) | inhibit | Positive | UC50 (nmol/mg mitochondrial protein) | 40 | |
| Tolfenamic Acid | 3.4 ± 0.6 | rat | isolated rat liver mitochondria | State 2 respiration ( 96-well plate format using a phosphorescent oxygen-sensitive probe MitoXpress) | inhibit | Positive | UC50 (nmol/mg mitochondrial protein) | 40 | |
| Mefenamic acid | 17.9 ± 2.2 | rat | isolated rat liver mitochondria | State 2 respiration ( 96-well plate format using a phosphorescent oxygen-sensitive probe MitoXpress) | inhibit | Positive | UC50 (nmol/mg mitochondrial protein) | 40 | |
| Meloxicam | 22.8 ± 2.8 | rat | isolated rat liver mitochondria | State 2 respiration ( 96-well plate format using a phosphorescent oxygen-sensitive probe MitoXpress) | inhibit | Positive | UC50 (nmol/mg mitochondrial protein) | 40 | |
| Sudoxicam | 37.4 ± 3.0 | rat | isolated rat liver mitochondria | State 2 respiration ( 96-well plate format using a phosphorescent oxygen-sensitive probe MitoXpress) | inhibit | Positive | UC50 (nmol/mg mitochondrial protein) | 40 | |
| Piroxicam | 69.0 ± 7.2 | rat | isolated rat liver mitochondria | State 2 respiration ( 96-well plate format using a phosphorescent oxygen-sensitive probe MitoXpress) | inhibit | Positive | UC50 (nmol/mg mitochondrial protein) | 40 | |
| Diflunisal | 6.7 ± 1.3 | rat | isolated rat liver mitochondria | State 2 respiration ( 96-well plate format using a phosphorescent oxygen-sensitive probe MitoXpress) | inhibit | Positive | UC50 (nmol/mg mitochondrial protein) | 40 | |
| Diclofenac | 56.3 ± 4.9 | rat | isolated rat liver mitochondria | State 2 respiration ( 96-well plate format using a phosphorescent oxygen-sensitive probe MitoXpress) | inhibit | Positive | UC50 (nmol/mg mitochondrial protein) | 40 | |
| Sulindac | > 100 | rat | isolated rat liver mitochondria | State 2 respiration ( 96-well plate format using a phosphorescent oxygen-sensitive probe MitoXpress) | inhibit | Positive | UC50 (nmol/mg mitochondrial protein) | 40 | |
| Sulindac sulfide | 25.7 ± 4.5 | rat | isolated rat liver mitochondria | State 2 respiration ( 96-well plate format using a phosphorescent oxygen-sensitive probe MitoXpress) | inhibit | Positive | UC50 (nmol/mg mitochondrial protein) | 40 | |
| Nimesulide | 2.6 ± 0.2 | rat | isolated rat liver mitochondria | State 2 respiration ( 96-well plate format using a phosphorescent oxygen-sensitive probe MitoXpress) | inhibit | Positive | UC50 (nmol/mg mitochondrial protein) | 40 | |
| Sulindac sulfide | 39.8 ± 2.9 | rat | isolated rat liver mitochondria | State 3 respiration ( 96-well plate format using a phosphorescent oxygen-sensitive probe MitoXpress) | inhibit | Positive | IC50 (nmol/mg mitochondrial protein) | 40 | |
| Miconazole | I50=100, 160, 160, 170, 150 μM for substrates Glutamate/Malate, Pyruvate/Malate, Ornithine/Malate, Arginine/Malate and Succinate repectively | rat | liver mitochondria | Clark electrode | inhibit | Positive | 303 | ||
| clomipramine | increase | Positive | 22 | ||||||
| Nimesulide | Positive | 197 | |||||||
| Gentamicin | 5mM | 10min | rat | isolated rat liver (and kidney) mitochondria | Oroboros O2K Oxygraph, complex II-based state 3u respiration | decrease | Positive | 316 | |
| Gentamicin | 5mM | 10min | rat | isolated rat liver mitochondria | Oroboros O2K Oxygraph, complex I-based state 3u respiration | decrease | Positive | 316 | |
| Perhexiline | 200 μM | mouse; Crl/CD-l(1CR)BR Swiss | liver mitochondria | Measurement of oxygen uptake | increase | Positive | p < 0.01 | 193 | |
| Metformin | 2mM | 30 minutes | mouse; C57BL/6J | isolated skeletal muscle mitochondria | Measurement of Oxygen level; incubated in complex I substrate; added ADP (500 μM) | decrease | Positive | p < 0.05 | 172 |
| Metformin | 2mM | 30 minutes | mouse; C57BL/6J | isolated skeletal muscle mitochondria | Measurement of Oxygen level; incubated in complex I substrate; added oligomycin (2.5 μg oligomycin/mg mitochondrial protein) | decrease | Positive | p < 0.05 | 172 |
| Nitrofurantoin | 1 mM | mouse; C57B/6J | liver mitochondria | Measurement of oxygen uptake; used glutamate as substrate | decrease | Positive | p < 0.05; 61% inhibition | 13 | |
| Nitrofurantoin | 50 μM | mouse; C57B/6J | liver mitochondria | Measurement of oxygen uptake; used glutamate as substrate | decrease | Positive | p < 0.05; 72% inhibition | 13 | |
| Nitrofurantoin | 5 μM | mouse; C57B/6J | liver mitochondria | Measurement of oxygen uptake; used glutamate as substrate | decrease | Positive | p < 0.05; 38% inhibition | 13 | |
| Nitrofurantoin | 1 mM | mouse; C57B/6J | liver mitochondria | Measurement of oxygen uptake; used β-hydroxybutyrate as substrate | decrease | Positive | p < 0.05 | 13 | |
| Nitrofurantoin | 50 μM | mouse; C57B/6J | liver mitochondria | Measurement of oxygen uptake; used β-hydroxybutyrate as substrate | decrease | Positive | p < 0.05; 60% inhibition | 13 | |
| Nitrofurantoin | 5 μM | mouse; C57B/6J | liver mitochondria | Measurement of oxygen uptake; used β-hydroxybutyrate as substrate | decrease | Positive | p < 0.05 | 13 | |
| Nitrofurantoin | 1 mM | mouse; C57B/6J | liver mitochondria | Measurement of oxygen uptake; used α-ketoghttarate as substrate | decrease | Positive | p < 0.05 | 13 | |
| Nitrofurantoin | 50 μM | mouse; C57B/6J | liver mitochondria | Measurement of oxygen uptake; used α-ketoghttarate as substrate | decrease | Positive | p < 0.05; 70% inhibition | 13 | |
| Nitrofurantoin | 5 μM | mouse; C57B/6J | liver mitochondria | Measurement of oxygen uptake; used α-ketoghttarate as substrate | decrease | Positive | p < 0.05 | 13 | |
| nitrofurazone | 1mM | mouse; C57B/6J | liver mitochondria | Measurement of oxygen uptake | decrease | Positive | p < 0.05; 64% inhibition | 13 | |
| nitrofurazone | 1mM | mouse; C57B/6J | liver mitochondria | Measurement of oxygen uptake | decrease | Positive | p < 0.05; 63% inhibition | 13 | |
| Perhexiline | 200 μM | 5 minutes preincubation | mouse; Crl/CD-l(1CR)BR Swiss | liver mitochondria | Measurement of oxygen uptake | decrease | Positive | p < 0.01 | 193 |
| Perhexiline | 400 μM | 5 minutes preincubation | mouse; Crl/CD-l(1CR)BR Swiss | liver mitochondria | Measurement of oxygen uptake | decrease | Positive | p < 0.01 | 193 |
| nitrofurazone | 5μM | mouse; C57B/6J | mitoplasts | Measurement of oxygen uptake | decrease | Positive | p < 0.05 | 13 | |
| nitrofurazone | 5μM | mouse; C57B/6J | mitoplasts | Measurement of oxygen uptake | decrease | Positive | p < 0.05 | 13 | |
| Diazepam | 70 μg/ml | pig kidney embryo cells | polarographic cell (1.2 ml) | inhibit | Positive | 293 | |||
| buformin | 100 nmol/mg mitochondrial protein | rat; Sprague–Dawley | liver mitochondria | Meassurement of respiration | decrease | Positive | 15 | ||
| Phenformin | 100 nmol/mg mitochondrial protein | rat; Sprague–Dawley | liver mitochondria | Meassurement of respiration | decrease | Positive | 15 | ||
| Metformin | 500 nmol/mg mitochondrial protein | 40 minutes preincubation | rat; Sprague–Dawley | liver mitochondria | Meassurement of respiration | decrease | Positive | 15 | |
| buformin | 100 nmol/mg mitochondrial protein | 40 minutes preincubation | rat; Sprague–Dawley | liver mitochondria | Meassurement of respiration | decrease | Positive | 15 | |
| Phenformin | 100 nmol/mg mitochondrial protein | 40 minutes preincubation | rat; Sprague–Dawley | liver mitochondria | Meassurement of respiration | decrease | Positive | 15 | |
| buformin | 100 nmol/mg mitochondrial protein | rat; Sprague–Dawley | liver mitochondria | Meassurement of respiration | decrease | Positive | 15 | ||
| Phenformin | 100 nmol/mg mitochondrial protein | rat; Sprague–Dawley | liver mitochondria | Meassurement of respiration | decrease | Positive | 15 | ||
| Metformin | 500 nmol/mg mitochondrial protein | 40 min preincubation | rat; Sprague–Dawley | liver mitochondria | Meassurement of respiration | decrease | Positive | 15 | |
| buformin | 100 nmol/mg mitochondrial protein | 40 min preincubation | rat; Sprague–Dawley | liver mitochondria | Meassurement of respiration | decrease | Positive | 15 | |
| Phenformin | 100 nmol/mg mitochondrial protein | 40 min preincubation | rat; Sprague–Dawley | liver mitochondria | Meassurement of respiration | decrease | Positive | 15 | |
| Perhexiline | 100 μM | mouse; Crl/CD-l(1CR)BR Swiss | liver mitochondria | Measurement of oxygen uptake | increase | Positive | p < 0.01 | 193 | |
| Ketoconazole | I50=32, 74, 65, 75, 500μM for substrates Glutamate/Malate, Pyruvate/Malate, Ornithine/Malate, Arginine/Malate and Succinate repectively | rat | liver mitochondria | Clark electrode | inhibit | Positive | 303 | ||
| Perhexiline | 100 μM | mouse; Crl/CD-l(1CR)BR Swiss | liver mitochondria | Measurement of oxygen uptake | increase | Positive | p < 0.01 | 193 | |
| Perhexiline | 200 μM | mouse; Crl/CD-l(1CR)BR Swiss | liver mitochondria | Measurement of oxygen uptake | increase | Positive | p < 0.01 | 193 | |